Operating Lease, Right-of-Use Asset of RAPT Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: RAPT Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 30 Sep 2025.
RAPT Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,883,000, a 51% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

RAPT Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,883,000	-$1,942,000	-51%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$2,308,000	-$1,996,000	-46%	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$2,827,000	-$1,945,000	-41%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$3,333,000	-$1,895,000	-36%	31 Dec 2024	10-Q	06 Nov 2025	2025	Q3
Q3 2024	$3,825,000	-$1,847,000	-33%	30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$4,304,000	-$1,799,000	-29%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$4,772,000	-$1,754,000	-27%	31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$5,228,000	-$1,712,000	-25%	31 Dec 2023	10-K	06 Mar 2025	2024	FY
Q3 2023	$5,672,000	-$110,000	-1.9%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$6,103,000	+$48,000	+0.79%	30 Jun 2023	10-Q	11 Aug 2023	2023	Q2
Q1 2023	$6,526,000	+$204,000	+3.2%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$6,940,000			31 Dec 2022	10-K	07 Mar 2024	2023	FY
Q3 2022	$5,782,000			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$6,055,000			30 Jun 2022	10-Q	11 Aug 2022	2022	Q2
Q1 2022	$6,322,000			31 Mar 2022	10-Q	11 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.